ARVN
Arvinas Inc
NASDAQ: ARVN · HEALTHCARE · BIOTECHNOLOGY
$9.90
+0.81% today
Updated 2026-04-30
Market cap
$667.75M
P/E ratio
—
P/S ratio
2.54x
EPS (TTM)
$-1.14
Dividend yield
—
52W range
$6 – $15
Volume
0.9M
Arvinas Inc (ARVN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-19.40M | $5.11M | $-16.12M | $-40.63M | $-89.76M | $559.40M | $-273.50M | $-347.80M | $-259.30M | $-273.80M |
| Capital expenditures | $306667.00 | $1.01M | $2.83M | $6.24M | $6.45M | $4.70M | $6.80M | $2.90M | $1.80M | $1.90M |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $525586.00 | $245048.00 | $11.63M | $20.07M | $30.20M | $57.10M | $75.50M | $71.60M | $88.20M | $44.00M |
| Free cash flow | $-19.71M | $4.10M | $-18.95M | $-46.87M | $-96.20M | $554.70M | $-280.30M | $-350.70M | $-261.10M | $-275.70M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $60.50M | $3.42M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $-27.72M | $6.02M | $579.16M | $-475.60M | $-26.00M | — | — | — |